| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 1621 |
14:0 PC-d9|1,2-dimyristoyl-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9磷脂 |
484 |
axc |
2023-04-10 |
| 1622 |
14:0 PC-d63|1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 |
501 |
axc |
2023-04-10 |
| 1623 |
16:0 PC-d4|1,2-dipalmitoyl-sn-glycero-3-phosphocholine-1,1,2,2-d4磷脂 |
543 |
axc |
2023-04-10 |
| 1624 |
16:0 PC-d62|1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine磷脂 |
534 |
axc |
2023-04-10 |
| 1625 |
16:0-d31-18:1 PC|1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine 磷脂 |
534 |
axc |
2023-04-10 |
| 1626 |
N3-PEG6-CH2COOH 880129-82-8 Azide-PEG6-CH2COOH PEG试剂 |
493 |
LYQ |
2023-04-10 |
| 1627 |
16:0-Pyr PC|1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphatidylcholine|PC磷脂 |
1108 |
axc |
2023-04-10 |
| 1628 |
18:1(11-cis) PC|1,2-divaccenoyl -sn-glycero-3-phosphocholine|PC磷脂 |
493 |
axc |
2023-04-10 |
| 1629 |
16:1 (Δ9-Trans) PC|1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine|PC磷脂 |
607 |
axc |
2023-04-10 |
| 1630 |
18:1 (Δ9-Trans) PC|1,2-dielaidoyl-sn-glycero-3-phosphocholine|PC磷脂 |
1087 |
axc |
2023-04-10 |
| 1631 |
06:0 Lyso PC|1-hexanoyl-2-hydroxy-sn-glycero-3-phosphocholine 磷脂PC |
588 |
axc |
2023-04-07 |
| 1632 |
2-18:1 Lyso PC|1-hydroxy-2-oleoyl-sn-glycero-3-phosphocholine PC类磷脂 |
495 |
axc |
2023-04-07 |
| 1633 |
20:0 Lyso PC|1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine PC类磷脂 |
484 |
axc |
2023-04-07 |
| 1634 |
N3-PEG4-SPA 944251-24-5 PEG修饰剂 |
544 |
LYQ |
2023-04-07 |
| 1635 |
聚偏二氟乙烯/聚丙烯腈海水淡化膜 ，聚偏二氟乙烯/共六氟丙烯海水淡化膜 |
585 |
zyl |
2023-04-06 |
| 1636 |
mPEG6-N3 1043884-49-6 PEG修饰剂 |
503 |
LYQ |
2023-04-06 |
| 1637 |
酶抑制剂靶点预测|药物靶点评估|化合物库定制 |
736 |
zyl |
2023-04-04 |
| 1638 |
细胞膜修饰脂质体/蛋白/聚合物纳米载体/磁性纳米粒子 |
525 |
zyl |
2023-04-04 |
| 1639 |
cas:90429-66-6 Tempol-d17,15N 活性氧簇 |
575 |
axc |
2023-04-04 |
| 1640 |
Topo I/COX-2-IN-2 活性氧抑制剂运输条件 |
540 |
axc |
2023-04-04 |
| 1641 |
CAS：2133360-04-8 Pomalidomide-NH-CO-PEG1-N3 PEG衍生物 |
603 |
LYQ |
2023-04-04 |
| 1642 |
PEG衍生物 Thalidomide-O-PEG4-N3 2380318-57-8 萨力多胺-O-四聚乙二醇-叠氮 |
550 |
LYQ |
2023-04-04 |
| 1643 |
cas:2402735-14-0 DPP-4-IN-3 抗氧化小分子 |
499 |
axc |
2023-04-04 |
| 1644 |
cas:38216-54-5 Aureusidin 抗氧化抑制剂 |
528 |
axc |
2023-04-03 |
| 1645 |
cas:121009-77-6 Simvastatin acid 分子量436.58 活性氧 |
499 |
axc |
2023-04-03 |
| 1646 |
Biotin-PEG6-OH 906099-89-6 小分子PEG |
494 |
LYQ |
2023-04-03 |
| 1647 |
1.计算机辅助药物设计-活性/药物筛选 |
630 |
zyl |
2023-04-03 |
| 1648 |
关于PEG制备方法的简单介绍 |
827 |
LYQ |
2023-03-31 |
| 1649 |
Reactive oxygen species（ROS）活性氧响应的新型阳离子共聚物 |
891 |
zyl |
2023-03-30 |
| 1650 |
ROS浓度高低对细胞的影响，为什么要测ROS？ |
6114 |
zyl |
2023-03-30 |
| 1651 |
硫醇过氧化物酶在ROS信号传递中的作用 |
1017 |
zyl |
2023-03-30 |
| 1652 |
ROS活性氧有哪些检测方法？ |
1015 |
zyl |
2023-03-29 |
| 1653 |
活性氧Reactive Oxygen Species，ROS检测 |
578 |
zyl |
2023-03-29 |
| 1654 |
cas:916888-49-8 L-Acetyldopamine dimer-2 抗氧化抑制剂 |
544 |
axc |
2023-03-29 |
| 1655 |
cas:101314-97-0 Simvastatin hydroxy acid sodium辛伐他汀钠盐活性氧分子 |
610 |
axc |
2023-03-29 |
| 1656 |
Indirubin-3′-oxime Cas号：667463-82-3 Reactive Oxygen Species |
952 |
LYQ |
2023-03-29 |
| 1657 |
cas:102841-46-3 Moracin P 桑辛素P 活性氧抑制剂 |
597 |
axc |
2023-03-29 |
| 1658 |
cas:109-57-9 Allylthiourea 烯丙基硫脲 活性氧抑制剂 |
618 |
axc |
2023-03-28 |
| 1659 |
cas:16724-03-1 2-Selenouracil 活性氧簇 |
502 |
axc |
2023-03-28 |
| 1660 |
cas:28282-25-9 β-Elemonic acid β-岚香酮酸 ROS小分子 |
550 |
axc |
2023-03-28 |
| 1661 |
cas:113170-55-1 L-Ascorbic acid 2-phosphate magnesium 维生素C磷酸酯镁抗氧化抑制剂 |
722 |
axc |
2023-03-28 |
| 1662 |
cas:2031170-96-2 HKOH-1 抗氧化抑制剂 |
495 |
axc |
2023-03-28 |
| 1663 |
Cas号：228559-41-9 Ki8751 VEGFR2抑制剂(KI8751) 活性氧物种 |
580 |
LYQ |
2023-03-28 |
| 1664 |
Cas号：4338-47-0 Kinetin riboside 动力精核苷 活性氧物种 |
458 |
LYQ |
2023-03-28 |
| 1665 |
活性氧物种 Cas号：1589527-65-0 kira6 IRE1Α RNASE激酶抑制剂(KIRA6) |
520 |
LYQ |
2023-03-28 |
杏彩体育平台
微信公众号
官方微信